Gross Profit: Revenues from operations less the associated costs.
Crinetics Pharmaceuticals, Inc. (CRNX) had Gross Profit of $10.53M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$10.73M |
|
$-127.84M |
|
$0.20M |
|
|
Gross Profit |
$10.53M |
$151.11M |
|
$-140.38M |
|
$12.53M |
|
$-127.84M |
|
$-127.84M |
|
$-127.84M |
|
$-127.84M |
|
$-127.84M |
|
$-127.84M |
|
$-140.38M |
|
$-141.44M |
|
104.10M |
|
104.10M |
|
$-1.23 |
|
$-1.23 |
|
| Balance Sheet Financials | |
$1.32B |
|
$13.50M |
|
$78.91M |
|
$1.40B |
|
$71.09M |
|
-- |
|
$49.59M |
|
$120.68M |
|
$1.28B |
|
$1.28B |
|
$1.28B |
|
105.31M |
|
| Cash Flow Statement Financials | |
$-124.70M |
|
$-252.36M |
|
$389.88M |
|
$102.34M |
|
$115.14M |
|
$12.80M |
|
$29.68M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
18.60 |
|
-- |
|
-- |
|
-- |
|
-- |
|
98.14% |
|
-1307.79% |
|
-1307.79% |
|
-- |
|
-1191.03% |
|
-1191.03% |
|
$-125.52M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
0.07 |
|
1.89 |
|
47.65 |
|
-9.98% |
|
-9.98% |
|
-9.12% |
|
-9.98% |
|
$12.16 |
|
$-1.21 |
|
$-1.20 |
|